Terms of Service

1. Acceptance of Terms

By accessing or using withZeta ("Zeta", "Platform", "Service", "we", "us", or "our"), you agree to be bound by these Terms of Service ("Terms"). If you do not agree to these Terms, you may not access or use the Service.

These Terms constitute a legally binding agreement between you ("User", "you", or "your") and Lantern Pharma Inc. ("Lantern Pharma", "Company"). We reserve the right to update, modify, or replace these Terms at any time. Changes will be effective immediately upon posting to the Service. Your continued use of the Service after any changes constitutes acceptance of the new Terms.

Important: These Terms include disclaimers of warranties and limitations of liability that may affect your legal rights. Please read them carefully.

2. Description of Service

withZeta is an AI-powered research platform designed to accelerate rare cancer drug discovery and therapeutic development. The Service provides:

• Recursive AI reasoning for medical research queries
• Access to 35+ specialized medical databases and APIs
• Knowledge graph generation and visualization
• Literature synthesis and citation management
• Cheminformatics tools including blood-brain barrier prediction
• Clinical trial identification and analysis

Beta Status: The Service is currently in public beta. Features may change, performance may vary, and bugs are expected. See Section 6 for details on beta software limitations.

3. User Accounts & Access

3.1 Account Creation

To use the Service, you must create an account by providing:

• A valid email address
• Authentication via Google OAuth or email verification
• Your name (collected via OAuth or manual entry)

You agree to provide accurate, current, and complete information during registration and to update such information as necessary.

3.2 Beta Access Program

During the beta period, access to the Service may be invitation-only or subject to waitlist approval. Lantern Pharma reserves the right to approve, deny, or revoke beta access at its sole discretion.

3.3 Account Security

You are responsible for:

• Maintaining the confidentiality of your account credentials
• All activities that occur under your account
• Notifying us immediately of any unauthorized access or security breach

You may not share your account credentials with others or allow others to access your account. Lantern Pharma is not liable for any loss or damage arising from unauthorized account access.

3.4 Age Requirements

The Service is intended for users 18 years of age or older. Users between 13-17 must have parent or guardian consent. We do not knowingly collect personal information from children under 13.

4. Acceptable Use Policy

4.1 Permitted Uses

You may use the Service for:

• ✓ Research and educational purposes
• ✓ Drug discovery hypothesis generation
• ✓ Literature synthesis and evidence gathering
• ✓ Clinical trial identification
• ✓ Academic research projects
• ✓ Pharmaceutical R&D exploration

4.2 Prohibited Uses

You may NOT use the Service for:

• ✗ Diagnosing diseases in patients or providing medical advice
• ✗ Prescribing treatments or medications
• ✗ Replacing professional clinical judgment
• ✗ Direct patient care decisions
• ✗ Illegal drug synthesis or bioweapon development
• ✗ Automated scraping, bot access, or reverse engineering
• ✗ Circumventing rate limits or security measures
• ✗ Sharing account credentials with others
• ✗ Generating disinformation or fake medical studies
• ✗ Violating HIPAA, GDPR, or other privacy laws

For a complete list of prohibited activities, see our Acceptable Use Policy.

5. Intellectual Property Rights

5.1 User Input Ownership

You retain all ownership rights to the queries, questions, and text you submit to the Service ("User Input"). By submitting User Input, you grant Lantern Pharma a non-exclusive, worldwide, royalty-free license to process, store, and use your User Input solely to provide the Service.

5.2 Platform Ownership

Lantern Pharma owns all rights, title, and interest in:

• The Service's software, code, and infrastructure
• The withZeta brand, logos, and trademarks
• The proprietary Rare Cancers Knowledge Base
• AI models, algorithms, and system prompts

5.3 AI-Generated Output

AI-generated responses, knowledge graphs, and analyses produced by the Service ("Output") are provided under a non-exclusive, royalty-free license. You may use Output for research, publication, and commercial purposes, subject to the following:

• Attribution Required: Published research using Zeta must include attribution:Analysis assisted by withZeta AI Research Platform (Lantern Pharma Inc., 2026)
• No Warranty: Output is provided "as is" without guarantees of accuracy
• Independent Verification: You must verify all Output before relying on it for critical decisions

5.4 Third-Party Data Attribution

The Service integrates data from third-party sources including:

• PubMed/MEDLINE (U.S. National Library of Medicine)
• ORPHANET (European rare disease database)
• NCI Thesaurus (National Cancer Institute)
• ClinicalTrials.gov (U.S. clinical trials registry)
• Human Phenotype Ontology (HPO)

When using Output that includes third-party data, you must comply with the respective terms of each data source. PubMed citations must include PMID and DOI. ORPHANET data is subject to ORPHANET's terms of use.

6. Beta Software & Service Availability

6.1 Beta Status Acknowledgment

The Service is in public beta. By using the Service, you acknowledge and accept that:

• Features may change without notice
• Performance may vary significantly
• Bugs, errors, and system downtime are expected
• Data loss may occur (backup your important work)
• The Service may be discontinued at any time

6.2 No Uptime Guarantee

During beta, Lantern Pharma makes no guarantees regarding:

• Service availability or uptime
• Response time or latency
• Data persistence or backup
• Feature stability or consistency

6.3 Right to Modify or Discontinue

Lantern Pharma reserves the right to:

• Modify, suspend, or discontinue any feature at any time
• Change system limits (rate limits, conversation length, etc.)
• Terminate the beta program and transition to paid service
• Implement new features or remove existing ones

We will provide reasonable notice (minimum 30 days) before discontinuing the Service entirely.

6.4 Data Backup Responsibility

You are responsible for backing up important conversations and research outputs.While we make reasonable efforts to preserve your data, we cannot guarantee data persistence during beta. Use the export features to save critical work.

7. Subscription & Billing (Future)

7.1 Free Beta Credits

During the beta period, all users receive free beta credits to access the Service. Credit allocations may change at our discretion.

7.2 Future Paid Tiers

After the beta period, the Service may transition to a subscription model with paid tiers. Beta users will receive advance notice (minimum 60 days) before any charges are implemented.

Future subscription terms will include:

• Pricing tiers based on usage or features
• Auto-renewal terms and cancellation policies
• Refund policies (if applicable)
• Payment processing terms

7.3 No Current Charges

The Service is currently free during beta. You will not be charged without explicit consent and advance notice.

8. Disclaimers of Warranties

To the maximum extent permitted by law, Lantern Pharma disclaims all warranties, express or implied, including but not limited to:

• Merchantability: No warranty that the Service is fit for commercial use
• Fitness for Particular Purpose: No guarantee the Service meets your specific needs
• Accuracy: No warranty that AI-generated content is accurate, complete, or current
• Non-Infringement: No guarantee that use of Output won't infringe third-party rights
• Availability: No guarantee of uninterrupted or error-free service

8.1 Not Medical Advice

THE SERVICE IS NOT INTENDED FOR MEDICAL DIAGNOSIS OR TREATMENT.AI-generated responses are for research purposes only and do not constitute medical, diagnostic, or clinical advice. Always consult qualified healthcare professionals for medical decisions.

See our Medical Disclaimer and Acceptable Use Policy for complete details.

8.2 AI Limitations

Large language models can:

• Generate factually incorrect information ("hallucinations")
• Cite non-existent studies or data
• Misinterpret medical literature
• Provide outdated information
• Make logical errors despite correct data

You are solely responsible for verifying all AI-generated content before relying on it.

9. Limitation of Liability

9.1 No Liability for Medical Decisions

LANTERN PHARMA IS NOT LIABLE FOR:

• Medical decisions made based on Service outputs
• Patient outcomes resulting from use of AI-generated content
• Misdiagnosis or mistreatment resulting from Service use
• Harm caused by reliance on inaccurate AI responses

9.2 No Liability for Business Losses

To the maximum extent permitted by law, Lantern Pharma shall not be liable for:

• Loss of profits, revenue, or business opportunities
• Loss of data or conversation history
• Costs of procurement of substitute services
• Research delays or failed experiments
• Drug development decisions based on Service outputs
• Indirect, incidental, special, consequential, or punitive damages

9.3 Damages Cap

In no event shall Lantern Pharma's total liability to you for all damages, losses, and causes of action exceed the amount you paid to Lantern Pharma for use of withZeta in the twelve (12) months preceding the claim.

During the free beta period, this cap is $0 USD.

9.4 Indemnification

You agree to indemnify, defend, and hold harmless Lantern Pharma, its officers, directors, employees, and agents from any claims, liabilities, damages, losses, costs, or expenses (including reasonable attorneys' fees) arising from:

• Your use or misuse of the Service
• Your violation of these Terms
• Your violation of any third-party rights (including intellectual property or privacy rights)
• Medical decisions made using Service outputs

10. Data Privacy & Security

10.1 Privacy Policy

Your use of the Service is governed by our Privacy Policy, which describes how we collect, use, and protect your personal information.

10.2 HIPAA Non-Compliance

Prohibited data includes:

• Patient names, dates of birth, or contact information
• Medical record numbers or health insurance information
• Social Security Numbers or government identifiers
• Diagnostic codes or treatment records linked to individuals

10.3 Data Security

We implement industry-standard security measures including:

• Encryption in transit (TLS/SSL)
• Encryption at rest (AWS KMS)
• IAM role-based access control
• Regular security audits

However, no system is 100% secure. Use the Service at your own risk.

10.4 User Data Rights

You have the right to:

• Access your conversation history (export feature)
• Delete individual conversations or your entire account
• Request data portability (email contact@withzeta.ai)
• Opt-out of marketing communications

11. Termination

11.1 Termination by User

You may terminate your account at any time by:

• Deleting your account via account settings, or
• Emailing contact@withzeta.ai with your termination request

Upon termination, your conversation history and personal data will be deleted within 30 days (subject to legal retention requirements).

11.2 Termination by Lantern Pharma

We reserve the right to suspend or terminate your account immediately, without notice, if:

• You violate these Terms or our Acceptable Use Policy
• You engage in illegal activities using the Service
• You abuse system resources or attempt unauthorized access
• We determine your use poses a security or safety risk

11.3 Effect of Termination

Upon termination:

• Your access to the Service will be immediately revoked
• Your conversation history will be scheduled for deletion (30-day grace period)
• Unpaid fees (if applicable in future) remain due
• Sections 5 (IP), 8 (Disclaimers), 9 (Liability), and 12 (Disputes) survive termination

12. Dispute Resolution

12.1 Governing Law

These Terms are governed by the laws of the State of Delaware, United States, without regard to conflict of law principles.

12.2 Informal Resolution

Before filing a legal claim, you agree to attempt informal resolution by contacting us at info@lanternpharma.com. We will attempt to resolve disputes in good faith within 30 days.

12.3 Binding Arbitration (Optional)

If informal resolution fails, either party may elect binding arbitration under the American Arbitration Association (AAA) rules. Arbitration will be conducted in Dallas, Texas, and costs will be split equally.

Arbitration Opt-Out: You may opt-out of arbitration by emailing info@lanternpharma.com within 30 days of accepting these Terms with subject line "Arbitration Opt-Out".

12.4 Class Action Waiver

YOU AND LANTERN PHARMA AGREE THAT DISPUTES WILL BE RESOLVED INDIVIDUALLY, NOT AS CLASS ACTIONS OR CONSOLIDATED PROCEEDINGS.

12.5 Small Claims Court Exception

Either party may bring an individual action in small claims court instead of arbitration if the claim qualifies.

13. Miscellaneous

13.1 Entire Agreement

These Terms, together with our Privacy Policy and Acceptable Use Policy, constitute the entire agreement between you and Lantern Pharma regarding the Service.

13.2 Severability

If any provision of these Terms is found to be unenforceable, the remaining provisions will remain in full force and effect.

13.3 No Waiver

Failure by Lantern Pharma to enforce any right or provision of these Terms does not constitute a waiver of that right or provision.

13.4 Assignment

You may not assign or transfer these Terms or your account without our prior written consent. Lantern Pharma may assign these Terms to any successor or acquirer without restriction.

13.5 Force Majeure

Lantern Pharma is not liable for delays or failures in performance caused by events beyond our reasonable control (natural disasters, pandemics, wars, cyberattacks, AWS outages, etc.).

13.6 Export Compliance

You agree to comply with all applicable export control laws and regulations. You may not use the Service in violation of U.S. export restrictions.

14. Contact Information

For questions, concerns, or notices regarding these Terms, please contact us at:

Lantern Pharma Inc.
Email: info@lanternpharma.com
Address: Dallas, Texas, United States
Website: lanternpharma.com

Last Updated: January 16, 2026

Version 1.0 (Beta)